Pharmacology, Toxicology and Pharmaceutical Science
Cytokine
100%
Clinical Trial
100%
Nuclear Factor
100%
Prothrombin
100%
Sulforaphane
100%
Leukopenia
100%
Cytoprotective Agent
100%
Inflammation
100%
Anti-Inflammatory Drug
100%
Cytoprotection
100%
Antiinflammatory Activity
100%
Bardoxolone Methyl
100%
Lung Fibrosis
100%
SARS Coronavirus
100%
Adult Respiratory Distress Syndrome
100%
Cytokine Storm
100%
Medicine and Dentistry
COVID-19
100%
Clinical Trial
50%
Nuclear Factor
50%
T Lymphocyte
50%
Immune Response
50%
Sulforaphane
50%
Cytoprotective Agent
50%
Anti-Inflammatory Drug
50%
Cytoprotection
50%
Antiinflammatory Activity
50%
Prothrombin
50%
Pulmonary Fibrosis
50%
Bardoxolone Methyl
50%
Protein Homeostasis
50%
Cytokine Release
50%
Alveolar Cell
50%
Severe Acute Respiratory Syndrome Coronavirus 2
50%
Acute Respiratory Distress Syndrome
50%
Cytokine Storm
50%
Leukopenia
50%
Virus
50%
Biochemistry, Genetics and Molecular Biology
Immune Response
100%
Clinical Trial
100%
Proinflammatory Cytokine
100%
T Cell
100%
Sulforaphane
100%
Antiinflammatory Activity
100%
Cell Protection
100%
Protein Homeostasis
100%
Cytokine Release
100%
Cytokine Storm
100%
SARS Coronavirus
100%
Keyphrases
Nuclear Factor Erythroid 2-related Factor 2 (Nrf2)
100%
COVID-19
100%
Virus
33%
Clinical Trials
33%
Inflammatory Cytokines
33%
T Cells
33%
Sulforaphane
33%
Nuclear Factor-erythroid 2 p45-related Factor 2
33%
Leukopenia
33%
Inflammation Resolution
33%
Efficacy Data
33%
Cytoprotection
33%
Redox Homeostasis
33%
Anti-inflammatory Effect
33%
Pharmacological Activation
33%
Armamentarium
33%
Protein Homeostasis
33%
Cytokine Release
33%
Alveolar Cells
33%
Bardoxolone Methyl
33%
Cytokine Storm
33%
Lung Fibrosis
33%
Acute Respiratory Distress Syndrome
33%
Anti-inflammatory Strategies
33%
Safety Information
33%
Dysregulated Host Response
33%